Largest-ever study of psychedelics could help advance their use in treating mental health disorders
Peer-Reviewed Publication
Updates every hour. Last Updated: 15-Jun-2026 13:15 ET (15-Jun-2026 17:15 GMT/UTC)
Scientists have demonstrated, for the first time, that several psychedelic drugs – including psilocybin, LSD, mescaline, DMT and ayahuasca – produce a common pattern of brain activity despite their distinct chemistries.
An international consortium led by a McGill University researcher pooled brain imaging data from labs across five countries, creating the largest study of its kind to date.
A new study of more than 4 million cases finds that adults who never married face nearly double the cancer risk—especially for preventable cancers tied to smoking, infection and reproductive factors. These findings suggest that marital status could help target screening and prevention efforts.
(WASHINGTON, Apr. 8, 2026) — The American Society of Hematology (ASH) and the International Society on Thrombosis and Haemostasis (ISTH) released comprehensive clinical practice guidelines on anticoagulant prophylaxis in non-cardiac pediatric patients at risk of venous thromboembolism (VTE). The guidelines were developed by an expert panel following a rigorous review process and published in ASH’s peer-reviewed journal, Blood Advances.
New research finds that exposure to PFAS may weaken the immune system in adults, raising new concerns about the long-term health effects of these widely used chemicals.
A research paper by scientists from Suining Central Hospital proposed a novel residual-guided spatiotemporal transformer with graph fusion enhancement (RST2G) framework for precise breast tumor segmentation in ynamic contrast-enhanced magnetic resonance imaging (DCE-MRI).
The new research paper, published on Mar. 23 in the journal Cyborg and Bionic Systems, developed a groundbreaking deep learning framework for precise breast tumor segmentation in DCE-MRI.
MONTREAL – April 8, 2026 – The annual Society for Cardiovascular Angiography & Interventions (SCAI) meeting, SCAI Scientific Sessions 2026 & CAIC-ACCI Summit, will commence on Thursday, April 23, 2026, bringing thousands of researchers, clinicians, scientists, and innovators from around the world together to explore recent breakthroughs in the fields of interventional cardiology and endovascular medicine. Partnering with the Canadian Association of Interventional Cardiology/Association Canadienne de cardiologie d’intervention (CAIC-ACCI), the joint international conference will be held at the Palais des Congrès de Montréal in Montréal, Canada, from Thursday, April 23 to Saturday, April 25.